#

Search Reports


Healthcare » Medical Devices »

英雄联盟查询

  • ID:OGAMSC1908115
  • Published: August-2021
  • Pages:130
  • OGAnalysis
1 of 3

Global Antibiotics Market, Size, share, Outlook and Growth Opportunities to 2026: By Product Type (Cephalosporins, Fluroquinilones, Carbapenems, Penicillins, Aminoglycosides, Sulfonamides, Macrolides and Other Product Types), By Route of Administration (Oral, Intravenous, and Others), By Spectrum (Narrow-spectrum Antibiotics and Broad-spectrum Antibiotics) and By Region

Key Findings

  • Antibiotics Market is set to showcase CAGR of 2.2% in the forecasted period 2019-2026.
  • Carbapenems are anticipated to witness strong growth over the upcoming years.
  • Rise in health expenditure across developed regions imprints strong market value.
  • North America occupies major share in the global antibiotics market.
  • Strategic approaches are observed across key players of Antibiotics Market.
  • Upcoming regulatory environment is a key opportunity for further development of antibiotics in future.

Increase in the cases of infectious diseases among people as well as imbalance of demand-supply of antibiotics is fueling the growth of market. Improved standards of healthcare facilities and sophisticated treatment options have led to an increase in life expectancy rates leading to an increased aging population, this in turn drives the market demand.

Rising frequency of drug-resistant microbial strains and deficiency of antibiotics will encourage the key players operating in the industry to develop new antibiotics over the forecast period 2019-2026. For instance, in July 2019, Johnson & Johnson formed an “international research consortium” to focus on the discovery and development of new antibiotics for the treatment of tuberculosis.

Growing government support and reimbursement coverage will boost the product development and expansion over the forthcoming years. The regulatory and legislative environment has enhanced over the past decade for antibiotics developers, with some new incentives still in progress. The FDA has gone to great lengths to incentivize the development of next-generation antibiotics to make easy and quick entry of new drugs into the market.

North America currently dominates the antibiotics market and is expected to continue its strong hold owing to the increased adoption of antibiotics, with the United States recording the highest antibiotic prescribing rate.

Asia Pacific is expected to boost the antibiotics market share over the forecast period on account of large population base, high prevalence of infectious diseases, regulation reforms, and greater usage of generic medicines.

Development of antibiotic resistance and rise in drug approval costs are estimated to hamper the antibiotics market growth. On the contrary, introduction of new combination therapies and discovery of advanced prospect molecules to treat antibiotic-resistant microbial infections will offer future growth opportunities for market players.

Global Antibiotics Market Insights

The 2019 series of global market size, share, outlook, trends and growth prospects is a comprehensive analysis on global Antibiotics market conditions. Major trends shaping the near and long term future of the industry, opportunities, drivers and restraints of Antibiotics market, detailed porter’s five forces analysis and competitive insights are included in the research report.

Global Antibiotics Market Share by Product Type

The report presents the detailed annual outlook of each product type of the Antibiotics market to 2026. Cephalosporins, Fluroquinilones, Carbapenems, Penicillins, Aminoglycosides, Sulfonamides, Macrolides and other product types are included in the Antibiotics market report. Of these product types, Carbapenems are expected to occupy major share in the global industry.

Global Antibiotics Market forecasts by Route of Administration

The report provides detailed Antibiotics market forecasts by various routes of administrations including oral, intravenous, and others.  Among all routes, oral segment is forecasted to dominate the industry growth.

Global Antibiotics Market Size by Spectrum

The report presents in-depth insights into each of the leading Antibiotics spectrum along with annual forecasts to 2026. Various spectrums that are studied in the report include narrow-spectrum antibiotics and broad-spectrum antibiotics. Broad-spectrum antibiotic is the fastest growing segment.

Global Antibiotics Market Revenue by Region

The current Antibiotics market size in terms of revenue across 5 regions including North America, Europe, Asia Pacific, South & Central America and Middle East & Africa are studied in the report. In addition, historic data from 2017 and annual forecasts to 2026 are also included in the research report. Globally, North America is the major revenue contributor to the global market.

Global Antibiotics Market Analysis by Company

Top 10 leading companies in global Antibiotics market are analyzed in the report along with their business overview, operations, geographical locations, financial analysis, SWOT profile and Antibiotics products & services.

Global Antibiotics Market News and Recent Developments

Latest news and industry developments in terms of Antibiotics capacity expansions, acquisitions, organic & inorganic growth strategies, joint ventures and collaborations, product launches, market expansions etc are included in the report.

Scope

Long term perspective on the Antibiotics industry: 2019 (base year), 2019- 2026 (forecast period)

Antibiotics Market- Forecasts by Segments- Product Type, Route of Administration and Spectrum by geography.

  1. The research work categorizes the global Antibiotics market based on product type into 8 categories including Cephalosporins, Fluroquinilones, Carbapenems, Penicillins, Aminoglycosides, Sulfonamides, Macrolides and other product types.
  2. The report categorizes the market based on route of administration into 3 categories such as oral, intravenous, and others.
  3. It provides the market outlook based on spectrums into 2 types including narrow-spectrum antibiotics and broad-spectrum antibiotics.
  4. Antibiotics market across countries in 5 regions including North America, Europe, Asia-Pacific, South & Central America and Middle East & Africa are covered.

Antibiotics Market- Strategic Analysis Review

  1. Key strategies opted by leading players
  2. Short to Long Term Industry Trends
  3. Porter’s Five Forces Analysis
  4. Supply side and Demand Side Drivers and Challenges

Antibiotics Market- Growth Opportunities

  1. Potential New Business Opportunities
  2. Key Areas of Focus in forecast period

Antibiotics Market- Competitive Scenario

  1. 10 companies are analysed in the report including GlaxoSmithKline PLC, Johnson & Johnson Inc., Merck & Co. Inc., PfizerInc., Bayer Healthcare AG, Novartis AG, SanofiSA, Abbott Laboratories, Roche Holding AG and Astellas Pharma, Inc.
  2. Company Peer-to-Peer Comparison
  3. Company Profile and SWOT Analysis
  4. Financial Analysis

1 of 3

Table of Contents



1. Table of Contents
1.1 List of Tables
1.2 List of Figures



2. Introduction to Global Antibiotics Market
2.1 Global Antibiotics Market Snapshot, 2019
2.2 Antibiotics Industry Overview
2.3 Research Perspective



3. Global Antibiotics Market- Strategic Analysis 
3.1 Short Term and Long Term Industry Trends Affecting Global Antibiotics Market
3.2 Leading Antibiotics Types Targeted by Global Manufacturers 
3.3 Key Consumption Patterns of Antibiotics
3.4 Potential Markets Vital for business Expansion 
3.5 Five Forces Analysis
3.6 Drivers and Restraints



4. Global Antibiotics Market Outlook and Growth Opportunities by Product Type
4.1 Cephalosporins Market Outlook, 2019- 2026
4.2 Fluroquinilones Market Outlook, 2019- 2026
4.3 Carbapenems Market Outlook, 2019- 2026
4.4 Penicillins Market Outlook, 2019- 2026
4.5 Aminoglycosides Market Outlook, 2019- 2026
4.6 Sulfonamides Market Outlook, 2019- 2026
4.7 Macrolides Market Outlook, 2019- 2026
4.8 Other product types Market Outlook, 2019- 2026



5. Global Antibiotics Market Outlook and Growth Opportunities by Route of Administration
5.1 Oral Route Antibiotics Market Outlook, 2019- 2026
5.2 Intravenous Route Antibiotics Market Outlook, 2019- 2026
5.3 Other Routes of Antibiotics Market Outlook, 2019- 2026



6. Global Antibiotics Market Outlook and Growth Opportunities by Spectrum
6.1 Narrow-Spectrum Antibiotics Market Outlook, 2019- 2026
6.2 Broad-Spectrum Antibiotics Market Outlook, 2019- 2026



7. Asia Pacific Antibiotics Market Outlook and Growth Opportunities
7.1 Key Findings, 2019
7.2 Asia Pacific Antibiotics Market Outlook by Product Type, 2019- 2026
7.3 Asia Pacific Antibiotics Market Outlook by Route of Administration, 2019- 2026
7.4 Asia Pacific Antibiotics Market Outlook by Spectrum, 2019- 2026
7.5 Asia Pacific Antibiotics Market Outlook by Country, 2019- 2026



8. Europe Antibiotics Market Outlook and Growth Opportunities
8.1 Key Findings, 2019
8.2 Europe Antibiotics Market Outlook by Product Type, 2019- 2026
8.3 Europe Antibiotics Market Outlook by Route of Administration, 2019- 2026
8.4 Europe Antibiotics Market Outlook by Spectrum, 2019- 2026
8.5 Europe Antibiotics Market Outlook by Country, 2019- 2026



9. North America Antibiotics Market Outlook and Growth Opportunities
9.1 Key Findings, 2019
9.2 North America Antibiotics Market Outlook by Product Type, 2019- 2026
9.3 North America Antibiotics Market Outlook by Route of Administration, 2019- 2026
9.4 North America Antibiotics Market Outlook by Spectrum, 2019- 2026
9.5 North America Antibiotics Market Outlook by Country, 2019- 2026



10. South & Central America Antibiotics Market Outlook and Growth Opportunities
10.1 Key Findings, 2019
10.2 South & Central America Antibiotics Market Outlook by Product Type, 2019- 2026
10.3 South & Central America Antibiotics Market Outlook by Route of Administration, 2019- 2026
10.4 South & Central America Antibiotics Market Outlook by Spectrum, 2019- 2026
10.5 South & Central America Antibiotics Market Outlook by Country, 2019- 2026



11. Middle East & Africa Antibiotics Market Outlook and Growth Opportunities
11.1 Key Findings, 2019
11.2 Middle East & Africa Antibiotics Market Outlook by Product Type, 2019- 2026
11.3 Middle East & Africa Antibiotics Market Outlook by Route of Administration, 2019- 2026
11.4 Middle East & Africa Antibiotics Market Outlook by Spectrum, 2019- 2026
11.5 Middle East & Africa Antibiotics Market Outlook by Country, 2019- 2026



12. Competitive Landscape
12.1 Leading Players (Company Profile, SWOT Analysis, Antibiotics Products, Financial Analysis)
12.1.1 GlaxoSmithKline PLC 
12.1.2 Johnson & Johnson Inc.
12.1.3 Merck & Co. Inc.
12.1.4 PfizerInc.
12.1.5 Bayer Healthcare AG
12.1.6 Novartis AG
12.1.7 SanofiSA
12.1.8 Abbott Laboratories
12.1.9 Roche Holding AG
12.1.10 Astellas Pharma, Inc.
12.2 Company Benchmarking 
12.3 Financial Analysis



13. Recent News and Deals Landscape
13.1 Mergers and Acquisitions
13.2 New Product Launches
13.3 Asset Transactions
13.4 Financial Announcements



14. Appendix
14.1 OGAnalysis Expertise
14.2 Sources and Research Methodology
14.3 Contact Information



1 of 3

Type Delivery Format Details
Hard Copy A printed copy of the report will be shipped to you.
CD-ROM The report will be shipped to you in CD ROM format.
SINGLE USER Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows one specific user access to the product.
SITE LICENSE Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows all users within a given geographical location of your organization access to the product.
ENTERPRISEWIDE Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows all employees within your organization in different geographic locations access to the product.
1 - 5 USERS Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows up to five users have access to the product.
1 – 10 USERS Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows up to ten users have access to the product.
1 – 15 USERS Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows up to fifteen users have access to the product.
1 - 5 USERS Online Access (For Databases) Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. The license allows up to five users have access to the product.
1 - 10 USERS Online Access(For Databases) Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. The license allows up to ten users have access to the product.
1 - 15 USERS Online Access(For Databases) Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. The license allows up to fifteen users have access to the product.
1 - 5 USERS Electronic (Excel) The Excel spreadsheet will be emailed to you. The license allows up to five users have access to the product.


PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-10 user licence, allowing up to ten users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-15 user licence, allowing up to fifteen users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-15 user licence, allowing up to fifteen users have access to the product.